drugset / Trial / NCT02932280
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Phase 1/2
Active not recruiting
14 enrolled
Memorial Sloan Kettering Cancer Center
Alberta Children's Hospital · collabArkansas Children's Hospital Research Institute · collabM.D. Anderson Cancer Center · collabMilton S. Hershey Medical Center · collabPhoenix Children's Hospital · collabStanford University · collabUniversity of Texas · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety of neratinib at different dose levels and to find out what effects, good and bad, it has on the patients and the cancer.
Timeline
- Start
- 2016-10
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neratinib | Small molecule | — | Oral |